Nippon Roche acquires majority of Chugai
Roche's Japanese subsidiary Nippon Roche and Chugai Pharmaceutical Co. will merge to form an R&D-driven Japanese pharmaceutical company, which will leverage the strengths of both. The new company will retain the Chugai name and continue its listing on the Tokyo Stock Exchange.
- Partial Acquisition
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.